Cyclerion Therapeutics, Inc. Annual Return On Equity in % from 2018 to 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Cyclerion Therapeutics, Inc. quarterly/annual Return On Equity history and growth rate from 2018 to 2023.
  • Cyclerion Therapeutics, Inc. Return On Equity for the quarter ending June 30, 2024 was 28.1 %.
  • Cyclerion Therapeutics, Inc. annual Return On Equity for 2023 was -63.3 %, a 67.9% increase from 2022.
  • Cyclerion Therapeutics, Inc. annual Return On Equity for 2022 was -197 %, a 108% decline from 2021.
  • Cyclerion Therapeutics, Inc. annual Return On Equity for 2021 was -94.6 %, a 14.1% increase from 2020.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -63.3 +134 +67.9% Jan 1, 2023 Dec 31, 2023
2022 -197 -103 -108% Jan 1, 2022 Dec 31, 2022
2021 -94.6 +15.5 +14.1% Jan 1, 2021 Dec 31, 2021
2020 -110 +30.3 +21.6% Jan 1, 2020 Dec 31, 2020
2019 -140 -1.58K -110% Jan 1, 2019 Dec 31, 2019
2018 1.44K Jan 1, 2018 Dec 31, 2018
* An asterisk sign (*) next to the value indicates that the value is likely invalid.